Literature DB >> 18798635

Synthesis and in vivo evaluation of 4-deoxy-4,4-difluoro-KRN7000.

Leo Leung1, Cyrille Tomassi, Katrien Van Beneden, Tine Decruy, Dirk Elewaut, Tim Elliott, Aymen Al-Shamkhani, Christian Ottensmeier, Serge Van Calenbergh, Joern Werner, Tony Williams, Bruno Linclau.   

Abstract

The synthesis of 4-deoxy-4,4-difluoro-KRN7000 starting from phytosphingosine is described. Key steps include a regioselective benzylation of azidophytosphingosine and a deoxofluor-mediated fluorination of the corresponding 4-ketone. This fluorination failed completely when the adjacent 3-OH was protected as benzyl ether but proceeded well when a benzoyl group was used. The biological evaluation reveals a bias toward Th1 cytokine induction upon Natural Killer T cell activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18798635     DOI: 10.1021/ol801663m

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  The total synthesis of immunostimulant α-galactosylceramides from naturally configured α-galactoside raffinose.

Authors:  Zhenxing Zhang; Wei Zhao; Bin Wang; Chengfeng Xia; Wenpeng Zhang; Peng George Wang
Journal:  Org Lett       Date:  2011-08-04       Impact factor: 6.005

Review 2.  Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.

Authors:  James E East; Andrew J Kennedy; Tonya J Webb
Journal:  Med Res Rev       Date:  2012-12-13       Impact factor: 12.944

3.  Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.

Authors:  Barbara A Sullivan; Niranjana A Nagarajan; Gerhard Wingender; Jing Wang; Iain Scott; Moriya Tsuji; Richard W Franck; Steven A Porcelli; Dirk M Zajonc; Mitchell Kronenberg
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

Review 4.  Stimulation of natural killer T cells by glycolipids.

Authors:  Brian L Anderson; Luc Teyton; Albert Bendelac; Paul B Savage
Journal:  Molecules       Date:  2013-12-16       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.